Skip to main content
Veterinary Research logoLink to Veterinary Research
. 2025 Apr 10;56:79. doi: 10.1186/s13567-025-01512-0

Detection of prions in oocytes and ovaries of ewes naturally infected with classical scrapie

Paula A Marco Lorente 1, Maialen Zinkunegi 1, Diego Sola 1,, Nerea Larrañaga 1, Belén Marín 1, Bernardino Moreno 1, Juan J Badiola 1, Rosa Bolea 1, Alicia Otero 1
PMCID: PMC11984232  PMID: 40211373

Abstract

Classical scrapie is a prion disease that affects goats and sheep and is transmitted mainly horizontally. However, infection can also occur vertically, from mother to offspring, but the exact mechanism is unclear. The possibilities include transmission during pregnancy, birth, or after birth. Some studies have reported that prions are present in various reproductive tissues and fluids, suggesting that vertical transmission could occur through the germ line. However, the presence of prions in female reproductive tissues and oocytes has not been extensively studied, so their role in vertical transmission is unknown. Oocytes and ovarian tissues from 25 naturally infected ewes (ARQ/ARQ and VRQ/VRQ genotypes) and healthy controls were analysed. The samples were subjected to PMCA for prion detection. Histopathological and immunohistochemical evaluations of ovarian tissues were also performed. We demonstrated that PrPSc can accumulate in the oocytes and ovaries of scrapie-infected ewes, indicating a potential germline route of transmission. Prion accumulation appears to be influenced by the host genotype and prion strain, emphasizing the need for ultrasensitive detection techniques. Further research under controlled conditions is necessary to elucidate the mechanisms and implications for disease control and breeding programs.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13567-025-01512-0.

Keywords: Prion, PrPSc, classical scrapie, vertical transmission, ovaries, oocytes

Introduction

Scrapie is a transmissible spongiform encephalopathy (TSE) that naturally affects goats and sheep caused by the misfolding of the physiological protein PrPC (cellular prion protein) into the pathological isoform PrPSc, commonly known as prion, which is characterized by its self-replicating and infectious nature and its high resistance to radiation, heat, and proteases [13]. Owing to these properties, PrPSc cannot be degraded, leading to its accumulation and the formation of PrPSc deposits in various organs and tissues but primarily in the central nervous system (CNS), leading to a chronic neurodegenerative disorder with a slow progressive course and fatal outcome [46].

Classical scrapie is of particular concern to animal health because of its ability to spread within flocks. Transmission occurs mainly horizontally, either through direct contact between animals or indirectly through environmental contamination with prions released through excretions (faeces or urine), secretions (saliva or milk), carcasses, or placental remains of infected animals [710], the latter being considered the main source of contamination in this disease [1113]. However, infection can also occur through vertical or maternal routes. There is still uncertainty as to the exact timing and route by which this occurs. Three possibilities are suggested: prenatal transmission (between oogenesis and delivery) [1418], delivery (by contact with placenta or fluids) [7, 8, 13, 19] or after birth, which can occur by ingestion of contaminated colostrum or milk [2023] or contact with the environment contaminated by the placenta and other fluids of the infected mother [1214, 19, 24, 25].

To gain a clearer understanding of vertical transmission routes and their associated risk levels, several studies have been conducted on the accumulation of prions in various organs, tissues, fluids and cells associated with this route of transmission [9, 15, 18, 19, 2629]. Thus, positive results have been reported in the uterus [16], placenta, placentomes [28, 30, 31], amniotic fluid, umbilical cord, foetuses [15, 16, 32], and even semen [9], suggesting the potential for vertical transmission through the germ line. However, to our knowledge, no study has been conducted on the presence of prions in oocytes from naturally scrapie-infected ewes, so it is unknown whether the female germline could play a role in the transmission of the disease. In addition, studies on the role of the ovary in scrapie are scarce, and the presence of PrPSc deposits in this organ has never been reported [26, 28, 33]. Nevertheless, studies on the ovaries of infected females from different species, such as Rocky Mountain elk, deer with chronic wasting disease (CWD) and even humans with variant Creutzfeldt-Jakob disease (vCJD), have yielded positive results [3436], especially those that have resorted to ultrasensitive techniques such as protein misfolding cyclic amplification (PMCA) or real-time quaking-induced conversion (RT-QuIC) [3537]. Since neither of these techniques have been employed on ovaries from scrapie-infected ewes, their importance in disease transmission may have been underestimated.

Therefore, the main objective of this study was to investigate the presence of prions in the oocytes and ovaries of sheep naturally infected with classical scrapie using the ultrasensitive technique PMCA. Moreover, given that multiple studies indicate that genotype [3842] and prion strain [4346] can affect prion accumulation in peripheral tissues, including the reproductive system, this study also sought to assess potential differences in prion accumulation in the ovaries and oocytes of sheep of two genotypes (ARQ/ARQ and VRQ/VRQ) and sheep originating from two distinct scrapie outbreaks.

Materials and methods

Ethics statement

This study was approved by the Ethical Advisory Commission for animal experimentation of the University of Zaragoza (identification code: P138/15) and was performed under their supervision. All procedures involving animals adhered to the guidelines included in the Spanish law for Animal Protection RD53/2013 and the European Union Directive 2010/63 on the protection of animals used for experimental purposes.

Sample origin

Ovary samples from 25 naturally scrapie-infected ewes and 5 negative controls were analysed (Table 1) and divided into two studies. In the first study, we analysed the influence of genotype on prion accumulation in the oocytes and ovaries of 3 VRQ/VRQ and 8 ARQ/ARQ ewes from flocks in six different villages in Aragón (Spain). It was not possible to obtain and test more naturally infected VRQ/VRQ sheep due to the policies of prevention and eradication of classical scrapie (based on genetic selection of resistant breeders to reduce the prevalence of more susceptible genotypes, especially VRQ/VRQ). In the second study, the influence of the prion strain was evaluated in the oocytes and ovaries of 20 ARQ/ARQ ewes, 9 from a flock from village A and 11 from a flock from village B. Euthanasia was performed by intravenous overdose of pentobarbital. The ovaries were stored in the tissue bank of the Centro de Encefalopatías y Enfermedades Transmisibles Emergentes (University of Zaragoza, Spain), one of which was preserved frozen at −80 °C and the other in 10% formalin. In addition, as a negative control, ovaries from healthy ewes were selected from farms where no cases of classical scrapie had ever been reported.

Table 1.

Negative controls and naturally scrapie-affected ewes under study

Sheep ID Genotype Village Stage of disease Age
2121 ARQ/ARQ A Terminal 7
2177 ARQ/ARQ A Terminal 4
2123 ARQ/ARQ A Advanced clinical 4
2124 ARQ/ARQ A Clinical 4
2126 ARQ/ARQ A Clinical 4
2158 ARQ/ARQ A Clinical 4
2176 ARQ/ARQ A Clinical 3
2125 ARQ/ARQ A Clinical 3
2178 ARQ/ARQ A Advanced clinical 3
1608 ARQ/ARQ B Advanced clinical 6
1611 ARQ/ARQ B Advanced clinical 5
1679 ARQ/ARQ B Advanced clinical 5
1603 ARQ/ARQ B Advanced clinical 4
1635 ARQ/ARQ B Clinical 3
1555 ARQ/ARQ B Clinical 2
1681 ARQ/ARQ B Advanced clinical 2
1685 ARQ/ARQ B Advanced clinical 2
1667 ARQ/ARQ B Advanced clinical 2
1538 ARQ/ARQ B Advanced clinical 1
1644 ARQ/ARQ B Advanced clinical 1
1670 ARQ/ARQ C Advanced clinical 6
1637 ARQ/ARQ D Clinical 3
1510 VRQ/VRQ D Advanced clinical 5
2370 VRQ/VRQ E Advanced clinical 1
1404 VRQ/VRQ F Clinical 4
Negative controls
 NOv1 ARQ/ARQ G 3
 NOv2 ARQ/ARQ G 3
 NOv3 ARQ/ARQ G 4
 NOv4 ARQ/ARQ H 3
 NOv5 ARQ/ARQ H 3

Oocyte retrieval and trypsinization

After the ovaries were thawed at 4 °C for 12–24 h, a Petri dish was prepared with 5 mL of 1× PBS at 37 °C for each ovary. In this dish, the ovary was dissected with sterile forceps and a scalpel. The visible follicles were punctured with a sterile needle, and longitudinal cuts were made on the external surface to extract as many oocytes as possible. A stereomicroscope was used to identify the oocytes, which were aspirated with a micropipette and deposited in PCR tubes. The oocyte plasma membrane and zona pellucida were removed by trypsinization for subsequent analysis by PMCA. For this purpose, oocytes were incubated at room temperature for 60–90 s with 5 μL of 0.25% porcine trypsin (SIGMA Trypsin–EDTA Solution (10X)) in Hanks’ balanced salt (1x), w/o Ca & Mg, w/o phenol red (400 mg/L KCl, 1000 mg/L d-glucose, 60 mg/L KH2PO4, 8000 mg/L NaCl, 350 mg/L NaHCO3, 48 mg/L Na2HPO4), and trypsinization was stopped by the addition of 5 μL of protease inhibitor (Complete, Sigma Aldrich).

Prion detection in oocytes and ovarian tissue homogenates by PMCA

Prior to PMCA, ovarian tissue homogenates were prepared at 10% w/v (weight/volume) in distilled water (H2Od) after oocyte retrieval, ensuring that no oocytes remained in the ovary. The absence of oocytes in the remaining tissue was verified by deep cutting and manual crushing of the ovaries, followed by examination of the liquid and the released tissues with a stereomicroscope prior to their introduction into the tissue homogenizer.

Seeds (trypsinized oocytes and 10% w/v ovarian tissue homogenates) were subjected to three rounds of PMCA (24 h each), as previously reported [47]. In each well of a 96-well PCR microplate (Axygen Scientific, USA), 10 μL of seeds were mixed with 60 μL of substrate (brain homogenates from negative tg338 mice, which express the VRQ allele of ovine PrPC) [48]. A Teflon bead (3 mm diameter) was added to each well. Amplification was conducted using a Qsonica Q700 sonicator with a water recirculation system. The microplates were subjected to 96 PMCA cycles, each consisting of 10 s of sonication at 75% power followed by 14 min and 50 s of incubation at 42 °C. After each 24-h PMCA round, 10 μL of the reaction mixture was transferred to a new microplate containing 60 μL of fresh substrate for the next round. Serial dilutions (10–1 to 10–8) of a tg338-passaged classical scrapie isolate (Daw) [48] and a classical ovine scrapie isolate obtained from the Aragón region, were used as positive controls, whereas uninfected sheep oocytes and ovaries and unseeded substrate were used as negative controls.

PrPSc detection after PMCA was performed by dot blot. In each well of a 96-well PCR microplate, the products of the third round of PMCA were subjected to digestion and denaturation by mixing 18 μL of each product with 2 μL of 3% SDS and 5 μL of a 0.5 μg/μL dilution of Proteinase K (Roche) in the RIPA Lysis Buffer System (Santa Cruz Biotechnology). This mixture was incubated at 37 °C for 1 h, and then digestion was stopped by adding 25 μL of Laemmli buffer to each well and heating at 95 °C for 5 min. A 10-μL volume of each well was mixed with 22.5 μL of 1% SDS and 22.5 μL of 1X PBS, and the samples were then vacuum transferred onto a nitrocellulose membrane. After the membrane was blocked for 30 min with 5% milk powder in wash buffer (10 mM sodium phosphate; 0.15 M NaCl; 0.05% Tween-20; 950 mL H2O; pH 7.5), PrPSc immunodetection was performed with the monoclonal antibody Sha31 (mAb, 1:8000, SPI-Bio), an HRP-conjugated anti-mouse secondary antibody (1:5000; Bio-Rad) and an enhanced chemiluminescence (ECL) substrate (Pierce) to reveal peroxidase activity.

Upon completion of the dot blot procedure, western blotting was conducted to confirm positive results. Twenty microlitres of PK-digested PMCA products from the dot blot were subjected to 12% SDS‒PAGE and transferred to a PVDF membrane. Then, the membrane was blocked for 30 min with 5% milk powder in wash buffer, and the same procedure used for the dot blot was used for immunodetection of PrPSc.

To quantify the signal intensity in the dot blots and western blots obtained after PMCA and assign results as “positive” or “negative”, a densiometric analysis was performed using ImageJ software (NIH). For background correction, the mean intensity of the negative controls was measured and subtracted from the test sample values. A positivity threshold was set as the mean plus two standard deviations (Mean + 2SD) of the negative controls. Samples with intensity values above this threshold were considered positive.

Prion detection in ovaries

Tissues fixed in formalin were processed according to standard histopathological protocols. The sections (4 µm thick) were stained with haematoxylin and eosin for histopathological analysis.

The possible presence of PrPSc in ovarian tissues was evaluated via immunohistochemistry as previously described [49] using the monoclonal primary antibody L42 (1:500, R-Biopharm), which is located in the central region of the C-terminal globular domain of PrP (144FGNDYEDRYYRENMYRYPNQVYY166), in addition to the 6H4 (Prionics, Zurich, Switzerland), which recognizes a region of the C-terminus of the protein antibody (144DYDRYYRE152). Formic acid, proteinase K digestion (4 µg/mL) and hydrated autoclaving at 96 °C in citrate buffer were used for antigen retrieval.

Results

Prion detection in oocytes and ovarian tissue homogenates by PMCA

ARQ/ARQ sheep accumulate more prions in oocytes than VRQ/VRQ sheep do

In total, oocytes from 8 ARQ/ARQ and 3 VRQ/VRQ ewes were analysed. All ewes had shown clinical signs of scrapie, and most of them were in an advanced or even terminal stage of the disease (Table 1). Prion propagation after 3 rounds of PMCA was detected in the oocytes of 5/8 ARQ/ARQ ewes and only 1/3 VRQ/VRQ ewes (Figure 1A). The intensity of the dot blot signal of each propagated sample was compared with that produced by positive controls (serial 10–1 to 10–8 dilutions of a tg338-passaged classical scrapie isolate and a classical ovine scrapie isolate obtained from the Aragón region) after PMCA to estimate the amount of prions present in the oocyte samples. Oocytes obtained from healthy sheep were used as negative controls for the technique. Most oocyte samples (with the exception of 1 ARQ/ARQ sheep) were mildly positive. Seeding activity was not detected in the oocytes of healthy ewes. These results were subsequently confirmed by western blotting (Figure 1B).

Figure 1.

Figure 1

Detection of prions present in VRQ/VRQ- and ARQ/ARQ-infected sheep oocytes. A Dot blot results. Serial dilutions (10‒1–10‒8) of a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc) were used as positive controls. Uninfected sheep oocytes (NOv1, NOv2 and NOv3) and PMCA substrate (negative tg338 mouse brain homogenate) were used as negative controls. Each ewe was analysed in duplicate, except for ewes 1667 and 1644, since it was not possible to extract more oocytes. B Western blot results. The results from two positive controls are included: a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc).

Differences in prion accumulation and propagation in the oocytes and ovaries of ewes from different scrapie outbreaks

To test the role of the prion isolate in oocyte prion accumulation, seeding activity in oocytes from 20 naturally infected ARQ/ARQ ewes in flocks from two different villages was analysed by PMCA. Nine sheep were obtained from Village A, and 11 were obtained from Village B. The PMCA results were analysed by dot blotting, following a semiquantitative approach, and the seeding activity of each sample was compared with that of positive controls (serial 10–1 to 10–8 dilutions of a tg338-passaged classical scrapie isolate and a classical ovine scrapie isolate obtained from the Aragón region) and negative controls (uninfected PMCA substrate and oocytes from healthy ewes) (Figure 2A). Ovaries from 14 of these ewes were also analysed following the same procedure; however, in this case, ovaries from healthy ewes were used as negative controls (Figure 3A). All the ewes tested presented with clinical signs of scrapie, and most of them were in an advanced or even terminal stage of the disease (Table 1).

Figure 2.

Figure 2

Detection of prions present in oocytes of ARQ/ARQ-infected ewes from different scrapie outbreaks. A Dot blot results. Ewes belong to flocks from two different villages in Aragón (Spain). Serial dilutions (10‒1–10‒8) of a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc) were used as positive controls. Uninfected sheep oocytes (NOv4 and NOv5) and PMCA substrate (negative tg338 mouse brain homogenate) were used as negative controls. Each ewe was analysed in duplicate. B Western blot results. The results from two positive controls are included: a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc).

Figure 3.

Figure 3

Detection of prions present in the ovaries of ARQ/ARQ-infected ewes from different scrapie outbreaks. A Dot blot results. Ewes belong to flocks from two different villages in Aragón (Spain). Serial dilutions (10‒1–10‒8) of a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc) were used as positive controls. Uninfected sheep ovaries (NOv4 and NOv5) and PMCA substrate (negative tg338 mouse brain homogenate) were used as negative controls. Each ewe was analysed in duplicate. B Western blot results. The results from two positive controls are included: a tg338-passaged classical scrapie isolate (Daw) and a classical ovine scrapie isolate obtained from the Aragón region (O-Sc).

Oocyte analysis revealed 5/9 positive results in sheep from Village A and 11/11 positive results in sheep from Village B. In addition, the relative amount of PrPSc obtained in the oocytes of Village B after PMCA was greater than that of Village A (Figure 2A). Moreover, regarding ovarian tissue, no positive result was observed in Village A, as opposed to Village B, where all the ovaries analysed were positive for prion propagation (Figure 3A). PrPSc was not detected in the oocytes or ovaries of healthy ewes. These results were subsequently confirmed by western blotting (Figure 2B and Figure 3B).

No PrPSc could be detected by immunohistochemistry in the ovarian tissues from any of the VRQ/VRQ or ARQ/ARQ ewes included in the present study (Additional file 1).

Discussion

To our knowledge, this is the first report describing the presence of PrPSc in oocytes in naturally acquired classical scrapie. Several studies, however, have previously detected the presence of PRNP and PrP mRNA in various reproductive tissues and related cells, including ovaries, ovarian follicles, theca and granulosa cells and oocytes (especially immature ones) [19, 27, 50, 51], indicating that PrPSc has the necessary substrate to replicate in oocytes. In fact, it has been suggested that PrPC may play an important role in promoting ovarian follicle development [50]. Consequently, prion accumulation in oocytes seems plausible, which could indicate transmission through the germline.

On the other hand, certain differences in prion accumulation according to genotype were observed, as prion propagation seems to be detected in a larger number of oocyte samples from ARQ/ARQ ewes (Figure 1), although the VRQ/VRQ genotype is more susceptible to pathology. In addition, prion amplification in ARQ/ARQ oocytes was relatively more intense. It is widely known that cell specificity, kinetics and tissue distribution are influenced by different factors, with the PRNP genotype being one of the most significant [38, 39]. The PRNP genotype also determines susceptibility to infection. Previous studies have shown that VRQ/VRQ ewes have not only shorter incubation periods but also greater tissue dissemination of PrPSc than do ARQ/ARQ ewes in nervous and lymphoid tissues [5255]. However, this superior peripheral dissemination of PrPSc in VRQ/VRQ sheep might not occur in other tissues. For example, in a previous study on the presence of prions in foetuses of naturally infected sheep, the VRQ/VRQ genotype was associated with a very low level of infectivity and negative results in almost all the foetuses tested [16], whereas in another study, all the ARQ/ARQ foetuses tested were positive for prion accumulation [15]. Similarly, other authors reported extensive dissemination of PrPSc in peripheral organs outside the CNS and LRS of naturally infected ARQ/ARQ ewes, whereas VRQ/VRQ ewes were negative. These results were attributed to the slower progression of the pathology in ARQ/ARQ sheep than in VRQ/VRQ sheep, particularly in older animals. The extended incubation period in ARQ/ARQ sheep allows more time for PrPSc to disseminate throughout various peripheral organs [26].

However, in these studies, only a small number of VRQ sheep were analysed, and the same applies to the present study, in which sheep were also obtained from different geographical areas. Therefore, although differences were observed between ARQ/ARQ and VRQ/VRQ sheep, it is not possible to draw definitive conclusions about the effect of genotype on PrPSc accumulation in oocytes, as these disparities may also be linked to variations in prion strains affecting these flocks, which can affect peripheral PrPSc accumulation [4346]. Therefore, to investigate the influence of prion strains/isolates on prion accumulation in oocytes, seeding activity was analysed in oocytes collected from 20 ARQ/ARQ ewes from two distinct flocks located in 2 villages separated by 131 kms. Greater accumulation of PrPSc was detected in the oocytes and ovaries of ewes from Village B than in those from Village A. To our knowledge, this is the first report describing the presence of PrPSc in ovaries in naturally acquired classical scrapie by PMCA.

The ewes from both villages had the ARQ/ARQ genotype and were at approximately the same stage of pathology. However, the age of the affected sheep differed between flocks. Six of the eight ewes from Village A were ≥ 4 years old, whereas the scrapie-affected sheep from Village B were significantly younger (Table 1). Since we studied naturally infected sheep, we cannot determine the exact moment at which the animals were infected or, therefore, the incubation period. However, the young age of clinical sheep from Village B, together with the differential prion accumulation in oocytes and ovaries observed, suggests that these geographically distant outbreaks might be caused by different scrapie strains. In addition, the scrapie strain present in Village B may be more aggressive or better adapted to sheep of the ARQ/ARQ genotype. However, characterization studies in different mouse lines are needed to determine whether these outbreaks are caused by distinct strains. On the other hand, the results obtained in sheep from Village A suggest that prions either accumulate in oocytes or ovarian follicles at a relatively high rate or that this accumulation occurs earlier than their spread to the rest of the ovarian tissue, as oocytes tested positive when all ovarian samples were negative (Table 2). The exact reason for this remains unknown. This could be due to different levels of PrPC expression in the ovary and ovarian follicles, given the suggested importance of PrPC in follicular development [50] and the fact that prion tropism is also influenced by the differential expression of PrPC in different organs [56]. Similar results have been reported in other studies. For example, a study on CWD vertical transmission in deer suggested that prions accumulate at the maternal‒foetal interface rather than in maternal reproductive organs, as PrPSc was detected in the placentomes of infected females whose uterus and ovaries were negative by RT-QuIC [37]. Similarly, in another study, 6-day-old embryos from scrapie-infected ewes were transferred and implanted in healthy ewes, resulting in the development of the disease in offspring, which suggests that transmission occurs in the early stages of embryogenesis or with the germline [17].

Table 2.

Detection of PrPSc by PMCA and immunohistochemistry (IHC) in oocytes and ovaries of ARQ/ARQ and VRQ/VRQ ewes

Sheep ID Oocytes Ovaries
PMCA PMCA IHC
2121 +
2177 +
2123
2124 +
2126
2158
2176 +
2125
2178 +
1608 + Not tested
1611 + +
1679 + +
1603 + +
1635 + Not tested
1555 + +
1681 + +
1685 + +
1667 + Not tested
1538 + +
1644 + Not tested
1670 + Not tested
1637 Not tested
1510 + Not tested
2370 Not tested
1404 Not tested
Negative controls
NOv1 Not tested
NOv2 Not tested
NOv3 Not tested
NOv4
NOv5

Additionally, no PrPSc deposits were detected by immunohistochemistry in any of the ovaries, even those that tested positive for PMCA (Additional file 1). These results coincide with those of previous studies, where it was not possible to detect PrPSc by immunohistochemistry or ELISA in the ovaries of ewes with scrapie [26] or in the ovaries of deer with CWD. However, in the case of CWD-infected does, this was possible by PMCA, RT-QuIC and bioassays [37]. Consequently, it is deduced that prion accumulation in ovaries is too low to be detected by conventional techniques, and it is necessary to resort to ultrasensitive techniques for this purpose. This fact is logical considering that the neurons innervating the reproductive organs are associated with the most caudal segment of the spinal cord, the sacrum, which is located farther from the initial sites of invasion. Consequently, since prion infection progresses slowly from the thoracic part of the CNS to the sacral region, reproductive organs are among the last organs to be infected [26].

Our results show that PrPSc accumulation in the oocytes and ovaries of ewes naturally infected with classical scrapie is possible, suggesting potential transmission of the disease through the germ line. However, prion accumulation is too low to be detected by conventional techniques, and ultrasensitive techniques such as PMCA are necessary. These results highlight the importance of these techniques for future studies on the involvement of reproductive organs in the vertical transmission of scrapie. In addition, differences in prion accumulation in oocytes and ovaries may be associated with the prion strain involved and the genotype of the host. However, further studies are needed to analyse these factors under experimental conditions, with characterized prion strains and known incubation periods. Consequently, the findings of the present study highlight the need to continue investigating the possible routes of scrapie vertical transmission, as it may be necessary to implement new control and selection strategies in breeding programs to reduce the spread of the disease.

Supplementary Information

13567_2025_1512_MOESM1_ESM.tiff (808KB, tiff)

Additional file 1. Immunohistochemical (IHC) detection of PrPSc in ovaries (A) and haematoxylin‒eosin (HE) staining (B). No PrPSc deposits were detected in any of the ovaries analysed, not even those positive for PMCA. For example, the IHC (mAb L42; ×50) (A) and HE (×50) (B) results of VRQ/VRQ 1510 ewe ovaries (positive for classical scrapie) are included. No differences were found in the IHC and HE results from the ovaries of infected ARQ/ARQ ewes or negative controls.

Acknowledgements

The authors would like to thank Sandra Felices, Catarina Martinho and Daniel Romanos for their excellent technical assistance.

Authors' contributions

PAML and AO conceived and designed this study. PAML and MZ conducted the experiments and interpreted the findings. BM (Belén Marín), DS and AO carried out the necropsies. NL and DS collaborated in the experiments. PAML, NL and DS wrote the draft of the manuscript. JJB, RB, AO and BM (Bernardino Moreno) revised the manuscript. AO and RB acquired the funding. All authors read and approved the final manuscript.

Funding

This work was supported financially by POCTEFA EFA031/01 NEURO-COOP, which was 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg VI-A Spain-France-Andorra program (POCTEFA 2021–2027). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Availability of data and materials

All the data generated or analysed during this study are included in this published article.

Declarations

Ethics approval and consent to participate

All the animal experiments were approved by the Ethics Committee for Animal Experiments of the University of Zaragoza (permit number PI17/21). All authors consent to participate.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363–13383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272:6324–6331 [DOI] [PubMed] [Google Scholar]
  • 3.Houston F, Andréoletti O (2019) Animal prion diseases: the risks to human health. Brain Pathol 29:248–262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Orge L, Lima C, Machado C, Tavares P, Mendonça P, Carvalho P, Silva J, Pinto M, Bastos E, Pereira JC, Gonçalves-Anjo N, Gama A, Esteves A, Alves A, Matos AC, Seixas F, Silva F, Pires I, Figueira L, Vieira-Pinto M, Sargo R, Pires M (2021) Neuropathology of animal prion diseases. Biomolecules 11:466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Imran M, Mahmood S (2011) An overview of animal prion diseases. Virol J 8:493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Horiuchi M, Yamazaki N, Ikeda T, Ishiguro N, Shinagawa M (1995) A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J Gen Virol 76:2583–2587 [DOI] [PubMed] [Google Scholar]
  • 7.Mabbott NA (2017) How do PrPSc prions spread between host species, and within hosts? Pathogens 6:60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Detwiler LA, Baylis M (2003) The epidemiology of scrapie. Rev Sci Tech 22:121–143 [DOI] [PubMed] [Google Scholar]
  • 9.Rubenstein R, Bulgin MS, Chang B, Sorensen-Melson S, Petersen RB, LaFauci G (2012) PrPSc detection and infectivity in semen from scrapie-infected sheep. J Gen Virol 93:1375–1383 [DOI] [PubMed] [Google Scholar]
  • 10.Miller MW, Williams ES, Hobbs NT, Wolfe LL (2004) Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10:1003–1006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Foster JD, Hunter N, Williams A, Mylne MJA, McKelvey WAC, Hope J, Fraser H, Bostock C (1996) Observations on the transmission of scrapie in experiments using embryo transfer. Vet Rec 138:559–562 [DOI] [PubMed] [Google Scholar]
  • 12.Pattison IH, Hoare MN, Jebbett JN, Watson WA (1974) Further observations on the production of scrapie in sheep by oral dosing with foetal membranes from scrapie-affected sheep. Br Vet J 130:lxv–lxvii [DOI] [PubMed] [Google Scholar]
  • 13.Race R, Jenny A, Sutton D (1998) Scrapie infectivity and proteinase K-resistant prion protein in sheep placenta, brain, spleen, and lymph node: implications for transmission and antemortem diagnosis. J Infect Dis 178:949–953 [DOI] [PubMed] [Google Scholar]
  • 14.Hoinville LJ (1996) A review of the epidemiology of scapie in sheep. Rev Sci Tech 15:827–852 [DOI] [PubMed] [Google Scholar]
  • 15.Garza MC, Fernández-Borges N, Bolea R, Badiola JJ, Castilla J, Monleón E (2011) Detection of PrPres in genetically susceptible fetuses from sheep with natural scrapie. PLoS One 6:e27525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Spiropoulos J, Hawkins SAC, Simmons MM, Bellworthy SJ (2014) Evidence of in utero transmission of classical scrapie in sheep. J Virol 88:4591–4594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Foster JD, Goldmann W, Hunter N (2013) Evidence in sheep for pre-natal transmission of scrapie to lambs from infected mothers. PLoS One 8:e79433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Adams DB (2016) Prenatal transmission of scrapie in sheep and goats: a case study for veterinary public health. Open Vet J 6:194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tuo W, Zhuang D, Knowles DP, Cheevers WP, Man-Sun SY, O’Rourke KI (2001) PrP-C and PrP-Sc at the fetal-maternal interface. J Biol Chem 276:18229–18234 [DOI] [PubMed] [Google Scholar]
  • 20.Konold T, Moore SJ, Bellworthy SJ, Terry LA, Thorne L, Ramsay A, Salguero FJ, Simmons MM, Simmons HA (2013) Evidence of effective scrapie transmission via colostrum and milk in sheep. BMC Vet Res 9:99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Maddison BC, Baker CA, Rees HC, Terry LA, Thorne L, Bellworthy SJ, Whitelam GC, Gough KC (2009) Prions are secreted in milk from clinically normal scrapie-exposed sheep. J Virol 83:8293–8296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbière F, Cassard H, Costes P, Bergonier D, Weisbecker JL, Moldal T, Simmons H, Lantier F, Feraudet-Tarisse C, Morel N, Schelcher F, Grassi J, Andréoletti O (2008) Prions in milk from ewes incubating natural scrapie. PLoS Pathog 4:e1000238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ligios C, Cancedda MG, Carta A, Santucciu C, Maestrale C, Demontis F, Saba M, Patta C, DeMartini JC, Aguzzi A, Sigurdson CJ (2011) Sheep with scrapie and mastitis transmit infectious prions through the milk. J Virol 85:1136–1139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.González L, Dagleish MP, Martin S, Finlayson J, Sisó S, Eaton SL, Goldmann W, Witz J, Hamilton S, Stewart P, Pang Y, Steele P, Reid HW, Chianini F, Jeffrey M (2012) Factors influencing temporal variation of scrapie incidence within a closed Suffolk sheep flock. J Gen Virol 93:203–211 [DOI] [PubMed] [Google Scholar]
  • 25.Healy AM, Hannon D, Morgan KL, Weavers E, Dan Collins J, Doherty ML (2004) A paired case–control study of risk factors for scrapie in Irish sheep flocks. Prev Vet Med 64:73–83 [DOI] [PubMed] [Google Scholar]
  • 26.Garza MC, Monzón M, Marín B, Badiola JJ, Monleón E (2014) Distribution of peripheral PrPSc in sheep with naturally acquired scrapie. PLoS One 9:e97768 [DOI] [PMC free article] [PubMed]
  • 27.Thumdee P, Ponsuksili S, Murani E, Nganvongpanit K, Gehrig B, Tesfaye D, Gilles M, Hoelker M, Jennen D, Griese J, Schellander K, Wimmers K (2006) Expression of the prion protein gene (PRNP) and cellular prion protein (PrPc) in cattle and sheep fetuses and maternal tissues during pregnancy. Gene Expr 13:283–297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lacroux C, Corbière F, Tabouret G, Lugan S, Costes P, Mathey J, Delmas JM, Weisbecker JL, Foucras G, Cassard H, Elsen JM, Schelcher F, Andréoletti O (2007) Dynamics and genetics of PrPSc placental accumulation in sheep. J Gen Virol 88:1056–1061 [DOI] [PubMed] [Google Scholar]
  • 29.Bendheim PE, Brown HR, Rudelli RD, Scala LJ, Goller NL, Wen GY, Kascsak RJ, Cashman NR, Bolton DC (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42:149–156 [DOI] [PubMed] [Google Scholar]
  • 30.Andréoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, Lantier F, Berthon P, Eychenne F, Lafond-Benestad S, Elsen JM, Schelcher F (2002) PrPSc accumulation in placentas of ewes exposed to natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. J Gen Virol 83:2607–2616 [DOI] [PubMed] [Google Scholar]
  • 31.Tuo W, O’Rourke KI, Zhuang D, Cheevers WP, Spraker TR, Knowles DP (2002) Pregnancy status and fetal prion genetics determine PrP Sc accumulation in placentomes of scrapie-infected sheep. Proc Natl Acad Sci 99:6310–6315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Garza MC, Eraña H, Castilla J, Acín C, Vargas A, Badiola JJ, Monleón E (2017) Protein misfolding cyclic amplification corroborates the absence of PrPSc accumulation in placenta from foetuses with the ARR/ARQ genotype in natural scrapie. Vet Microbiol 203:294–300 [DOI] [PubMed] [Google Scholar]
  • 33.Hadlow WJ, Eklund CM, Kennedy RC, Jackson TA, Whitford HW, Boyle CC (1974) Course of experimental scrapie virus infection in the goat. J Infect Dis 129:559–567 [DOI] [PubMed] [Google Scholar]
  • 34.Notari S, Moleres FJ, Hunter SB, Belay ED, Schonberger LB, Cali I, Parchi P, Shieh WJ, Brown P, Zaki S, Zou WQ, Gambetti P (2010) Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 5:e8765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Selariu A, Powers JG, Nalls A, Brandhuber M, Mayfield A, Fullaway S, Wyckoff CA, Goldmann W, Zabel MM, Wild MA, Hoover EA, Mathiason CK (2015) In utero transmission and tissue distribution of chronic wasting disease-associated prions in free-ranging Rocky Mountain elk. J Gen Virol 96:3444–3455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nalls AV, McNulty E, Powers J, Seelig DM, Hoover C, Haley NJ, Hayes-Klug J, Anderson K, Stewart P, Goldmann W, Hoover EA, Mathiason CK (2013) Mother to offspring transmission of chronic wasting disease in Reeves’ muntjac deer. PLoS ONE 8:e71844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nalls AV, McNulty E, Hoover CE, Pulscher LA, Hoover EA, Mathiason CK (2017) Infectious prions in the pregnancy microenvironment of chronic wasting disease-infected Reeves’ muntjac deer. J Virol 91:e00501-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.O’Rourke KI, Baszler TV, Besser TE, Miller JM, Cutlip RC, Wells GAH, Ryder SJ, Parish SM, Hamir AN, Cockett NE, Jenny A, Knowles DP (2000) Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 38:3254–3259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jeffrey M, González L (2007) Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathol Appl Neurobiol 33:373–394 [DOI] [PubMed] [Google Scholar]
  • 40.Beekes M, McBride PA (2007) The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 274:588–605 [DOI] [PubMed] [Google Scholar]
  • 41.Hunter N (1997) PrP genetics in sheep and the implications for scrapie and BSE. Trends Microbiol 5:331–334 [DOI] [PubMed] [Google Scholar]
  • 42.Caplazi P, O’Rourke K, Wolf C, Shaw D, Baszler TV (2004) Biology of PrPsc accumulation in two natural scrapie-infected sheep flocks. J Vet Diagn Invest 16:489–496 [DOI] [PubMed] [Google Scholar]
  • 43.Lambert ZJ, Greenlee JJ, Cassmann ED, West Greenlee MH (2021) Differential accumulation of misfolded prion strains in natural hosts of prion diseases. Viruses 13:2453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Greenlee JJ (2019) Review: update on classical and atypical scrapie in sheep and goats. Vet Pathol 56:6–16 [DOI] [PubMed] [Google Scholar]
  • 45.Morales R, Abid K, Soto C (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772:681–691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Morales R, Hu PP, Duran-Aniotz C, Moda F, Diaz-Espinoza R, Chen B, Bravo-Alegria J, Makarava N, Baskakov IV, Soto C (2016) Strain-dependent profile of misfolded prion protein aggregates. Sci Rep 6:20526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferrière F, Richard CA, Laude H, Andréoletti O, Rezaei H, Béringue V (2014) Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. mBio 5:e00829-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vilotte J-L, Soulier S, Essalmani R, Stinnakre MG, Vaiman D, Lepourry L, Costa Da Silva J, Besnard N, Dawson M, Buschmann A, Groschup M, Petit S, Madelaine MF, Rakatobe S, Le Dur A, Vilette D, Laude H (2001) Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP. J Virol 75:5977–5984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Monleón E, Monzón M, Hortells P, Vargas A, Acín C, Badiola JJ (2004) Detection of PrPsc on lymphoid tissues from naturally affected scrapie animals: comparison of three visualization systems. J Histochem Cytochem 52:145–151 [DOI] [PubMed] [Google Scholar]
  • 50.Forde N, Rogers M, Canty MJ, Lonergan P, Smith GW, Coussens PM, Ireland JJ, Evans ACO (2008) Association of the prion protein and its expression with ovarian follicle development in cattle. Mol Reprod Dev 75:243–249 [DOI] [PubMed] [Google Scholar]
  • 51.Peralta OA, Huckle WR, Eyestone WH (2012) Developmental expression of the cellular prion protein (PrPC) in bovine embryos. Mol Reprod Dev 79:488–498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.González L, Dagleish MP, Martin S, Dexter G, Steele P, Finlayson J, Jeffrey M (2008) Diagnosis of preclinical scrapie in live sheep by the immunohistochemical examination of rectal biopsies. Vet Rec 162:397–403 [DOI] [PubMed] [Google Scholar]
  • 53.Ersdal C, Ulvund MJ, Espenes A, Benestad SL, Sarradin P, Landsverk T (2005) Mapping PrPSc propagation in experimental and natural scrapie in sheep with different PrP genotypes. Vet Pathol 42:258–274 [DOI] [PubMed] [Google Scholar]
  • 54.Jeffrey M, Martin S, Thomson JR, Dingwall WS, Begara-McGorum I, González L (2001) Onset and distribution of tissue PrP accumulation in scrapie-affected suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies. J Comp Pathol 125:48–57 [DOI] [PubMed] [Google Scholar]
  • 55.Keulen LJM, Schreuder BEC, Vromans MEW, Langeveld JPM, Smits MA (2000) Pathogenesis of natural scrapie in sheep. Prion diseases. Springer, Vienna, pp 57–71 [DOI] [PubMed] [Google Scholar]
  • 56.Béringue V, Tixador P, Andréoletti O, Reine F, Castille J, Laï T-L, Le Dur A, Laisné A, Herzog L, Passet B, Rezaei H, Vilotte JL, Laude H (2020) Host prion protein expression levels impact prion tropism for the spleen. PLoS Pathog 16:e1008283 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

13567_2025_1512_MOESM1_ESM.tiff (808KB, tiff)

Additional file 1. Immunohistochemical (IHC) detection of PrPSc in ovaries (A) and haematoxylin‒eosin (HE) staining (B). No PrPSc deposits were detected in any of the ovaries analysed, not even those positive for PMCA. For example, the IHC (mAb L42; ×50) (A) and HE (×50) (B) results of VRQ/VRQ 1510 ewe ovaries (positive for classical scrapie) are included. No differences were found in the IHC and HE results from the ovaries of infected ARQ/ARQ ewes or negative controls.

Data Availability Statement

All the data generated or analysed during this study are included in this published article.


Articles from Veterinary Research are provided here courtesy of BMC

RESOURCES